Armata Pharmaceuticals (ARMP) Amortization - Intangibles (2013)
Armata Pharmaceuticals' (ARMP) quarterly Amortization - Intangibles came in at $2.3 million in Q2 2013, up 670.3% quarter-over-quarter from $303000.0 in Q1 2013.
Armata Pharmaceuticals (ARMP) Amortization - Intangibles (2013) Analysis & Trends
Armata Pharmaceuticals has disclosed Amortization - Intangibles across 1 years of filings, most recently posting $2.3 million for Q2 2013.
- Amortization - Intangibles for Q2 2013 came in at $2.3 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2014 was $2.6 million (changed N/A YoY), and the FY2013 annual result was $2.6 million, changed N/A from the prior year.
- Amortization - Intangibles came in at $2.3 million for Q2 2013 at Armata Pharmaceuticals, up from $303000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $2.3 million in Q2 2013 to a low of $303000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 303,000.00 |